Navigation Links
ChemoCentryx in Medical News

ChemoCentryx to Present at The 9th World Congress on Inflammation in Tokyo, Japan

... treatment of inflammatory diseases." About chemocentryx ChemoCentryx, Inc. is a clinical-stage biophar...tary drug discovery and drug development platform, chemocentryx has internally generated multiple clinical and pre...nflammatory diseases such as rheumatoid arthritis. chemocentryx also has several programs in preclinical developme...

ChemoCentryx Appoints Edward E. Penhoet, Ph.D., to Board of Directors

...tary drug discovery and drug development platform, chemocentryx has internally generated several clinical and prec..., please refer to http://www.chemocentryx.com . chemocentryx believes that certain statements in this release m...tatements include, but are not limited to (i) that chemocentryx anticipates incurring significant losses for the f...
ChemoCentryx in Medical Technology

PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryx's Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference

... unparalleled clinical development progress by the chemocentryx team. This is true not only for our CCR9 program, ...ct T cells are thought to play an important role. chemocentryx has completed five Phase I clinical trials and one...ents have few options beyond surgery. About chemocentryx ChemoCentryx, Inc., is a clinical-stage biophar...

ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohn's Disease

... ChemoCentryx's Second-Generation CCR9 Program chemocentryx is also advancing a second-generation, orally-acti...ctant receptors. Under the terms of the agreement, chemocentryx is responsible for advancing product candidates th...clinical and discovery programs, clearly positions chemocentryx as an industry leader in chemokine-based therapeut...

ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354

...ith the dosing of the first patient in this trial, chemocentryx will be entitled to receive a $10 million mileston... as it emerges from the clinical trial program." chemocentryx and GSK's Center of Excellence for External Drug D...atory disorders. Under the terms of the agreement, chemocentryx is responsible for the discovery and development o...

ChemoCentryx Presents Positive Phase 2 Clinical Data for Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007 Conference

...ilar in both the placebo and Traficet-EN groups. chemocentryx is currently evaluating Traficet-EN in a large mul...nts have few or no options beyond surgery. About chemocentryx ChemoCentryx, Inc. is a clinical-stage biopharma...tary drug discovery and drug development platform, chemocentryx has internally generated several clinical and prec...
ChemoCentryx in Biological Technology

ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week

... (CDAI) score of at least 70 points. About chemocentryx ChemoCentryx, Inc., is a clinical-stage biopha...tary drug discovery and drug development platform, chemocentryx has internally generated multiple clinical and pre...flammatory diseases such as rheumatoid arthritis. chemocentryx also has several programs in preclinical developme...

ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist

...Chief Executive Officer. "I am gratified that the chemocentryx team has again demonstrated the broad capability o... between the C5a receptor and chemokine receptors, chemocentryx researchers successfully applied the company's pro...ptor targets covered under a 2006 alliance between chemocentryx and GlaxoSmithKline's Center of Excellence for Ext...

ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development

... "With the advancement of CCX025 into the clinic, chemocentryx can pursue a greater breadth of diseases associate...ptor targets covered under a 2006 alliance between chemocentryx and GlaxoSmithKline's Center of Excellence for Ext...tary drug discovery and drug development platform, chemocentryx has internally generated multiple clinical and pre...

ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth

...was discovered and characterized by ChemoCentryx. chemocentryx scientists, joined by researchers from the Univers...coded by a gene of previously unknown function) at chemocentryx through the company's proprietary EnabaLink Drug D...th high affinity to a specific chemokine receptor. chemocentryx has leveraged its EnabaLink Drug Discovery engine ...
Other Tags
(Date:11/23/2014)... New York, NY (PRWEB) November 23, 2014 ... ) that allege heart attacks, strokes, deep vein ... been filed in a federal multidistrict litigation (MDL) ... Liebhard LLP reports. , Court documents updated ... on Multidistrict Litigation (JPML) show the filing of ...
(Date:11/23/2014)... 23, 2014 Locks-Magnetic.com, a notable magnetic ... Moreover, all the new products are available at low ... manager is proud of the new emergency doors. The ... And customers can choose from several colors. All of ... quality emergency door release is not as easy as ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 SWAccessControl.com's high ... global market. Recently, the company has announced its new ... special offer on these high quality power suppliers. All ... 30% off. The special offer lasts until Dec. 20, ... many of them have been supporting it for a ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 Asher ... Medical Aesthetics & Wellness was recently featured on ... Ph.D. is president and CEO of American Medical Aesthetics ... Asher Milgrom received a full scholarship to attend an ... Medical School at the University of Chicago, where his ...
(Date:11/23/2014)... November 23, 2014 Syngenta lawsuits are ... behalf of farmers and agribusinesses that have allegedly incurred ... commercialize Agrisure Viptera and Agrisure Duracade, genetically modified ... approved for sale in China. According to a report ... virtually ban U.S. corn imports. Because China is the ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3
(Date:11/4/2014)... research study examining only marketing directed at children ... restaurants has found that the majority of black, ... such marketing tactics. , Authored by Arizona State ... study is the first to examine the use ... of fast food restaurants and its relationship to ...
(Date:11/3/2014)... , Nov. 3, 2014 Research and ... "Cell Therapy - Technologies, Markets and Companies" to ... cell therapy technologies and methods, which have already started to ... stem cell transplantation is replacing the old fashioned bone marrow ... Cell therapy is bound to become a part of medical ...
(Date:11/2/2014)... Physics World , James Dacey explores the ways in ... take their innovations from the lab into the commercial ... all start-up companies as they move from prototype to ... main factors: physics-based inventions are usually far from market-ready ... be a lot more complicated than had been originally ...
Breaking Biology News(10 mins):Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3The 'valley of death' facing physics start-ups 2
Other Contents